Skip to main content
    G

    Galectin Therapeutics Inc (GALT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.91
    -0.11 (-3.64%)

    Market Cap: $304.57M

    Last updated: Nov 17, 2026 at 4:18 PM ET

    Galectin Therapeutics Inc (GALT) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Galectin Therapeutics (GALT) has a latest price of $2.91 on Nov 17, 2026, 59.2% below its 52-week high of $7.13. Its price fell 47.2% over the past 12 months. The month-end price rose 361.1% over the 10 years through Oct 2026, a compound annual rate of 16.5%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $6.47 in Aug 2018 and its lowest $0.72 in Oct 2016, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart GALT with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GALT.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 20.7%, and over 6 months it rose 39.9%. The month-end price rose 62.7% over the 3 years through Oct 2026, a compound annual rate of 17.6%.

    PeriodChange
    1 month-16.7%
    3 months-20.7%
    6 months+39.9%
    12 months-47.2%
    12 months, with dividends-47.2%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+62.7%+17.6%
    5 years+4.7%+0.9%
    10 years+361.1%+16.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 240.9%, and its weakest was 2022, when it fell 45.4%.

    YearCloseChange
    2026 through Oct 2026$3.32-20.2%
    2025$4.16+222.5%
    2024$1.29-22.3%
    2023$1.66+46.9%
    2022$1.13-45.4%
    2021$2.07-7.6%
    2020$2.24-21.7%
    2019$2.86-16.6%
    2018$3.43+2.7%
    2017$3.34+240.9%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 19.0% below its 50-day average of $3.59 and 9.5% below its 200-day average of $3.21.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$2.91
    52-week high$7.13-59.2%
    52-week low$2.03+43.3%
    50-day average$3.59-19.0%
    200-day average$3.21-9.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 80.0%.

    MeasureValue
    1-year beta1.11
    Largest fall, 1 year-68.0%
    Largest fall, 3 years-80.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About GALT

    What is GALT's 1-year price change?

    Galectin Therapeutics's price fell 47.2% over the past 12 months. With dividends included, the 12-month total return was -47.2%.

    What is GALT's 5-year price change?

    Galectin Therapeutics's month-end price rose 4.7% over the 5 years through Oct 2026, a compound annual rate of 0.9%. These figures leave out dividends.

    What is GALT's 52-week high and low?

    Galectin Therapeutics's 52-week high is $7.13 and its 52-week low is $2.03. Its latest price of $2.91 on Nov 17, 2026 is 59.2% below the high.

    What is GALT's beta?

    Galectin Therapeutics's 1-year beta against the S&P 500 is 1.11, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 68.0%.

    Is the GALT chart free?

    Yes. Advanced Charting for GALT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.